The Compound Development Team Leader (CDTL) may work across disease areas (Rheumatology, Gastroenterology, and Immunodermatology) focused on the early portfolio assets. The CDTL will partner closely with the Portfolio & Asset Management organization as part of the wider CDTL community. They will lead a cross-functional compound development team to maximize the value of the asset and drives execution of the compound strategy. The CDTL champions the project(s) at all levels of J&J through providing clear communication, creative strategic approaches to development and securing appropriate resources to deliver on the milestones.The CDTL leads a cross-functional matrix compound development team to deliver against the asset strategy. Beginning at Lead Optimization entry the CDTL drives the development and execution of the compound strategy, working in close partnership with the Discovery Project Leader. The CDTL becomes the sole project team leader at New Molecular Entity Designation and is accountable for Phase 1-3 trials related to the compound development program.
Want more jobs like this?Getjobsdelivered to your inbox every week.
Want more jobs like this?
Getjobsdelivered to your inbox every week.
Select a locationGet Jobs
Select a location
